Effect of elexacaftor–tezacaftor–ivacaftor modulator on lung structure in cystic fibrosis V. Fainardi, K. Skenderaj, A. Ciuni, S. Esposito, N. Sverzellati, G. Pisi

Efficacy of elexacaftor-tezacaftor-ivacaftor in portuguese adolescents and adults with cystic fibrosis carrying non-F508del variants M.O. Pinto, A.S. Santos, S. Castanhinha

Changes in exercise endurance and inspiratory capacity after lumacaftor/ivacaftor therapy in cystic fibrosis D. Savi, A. Gramegna, M. Vicenzi, M. Di Paolo, B. Messore, P. Palange, F. Blasi